Newpharma Group logo

Newpharma Group

BE0684.465.652

Turnover
€ 60.94M ↑ 684% 2026 Total € 89.49M
Turnover growth
684.0% ↑ 691 pt 2026
Profit
€ 139K ↑ 428% 2026 Total € -7.66M
EBITDA
€ 3.56M ↑ 582% 2026 Total € -360K
EBITDA margin
5.9% ↓ 0.9 pt 2026
EBIT
€ 608K ↑ 418% 2026 Total € -4.74M
Net profit
€ 139K ↑ 428% 2026 Total € -7.66M
Net margin
0.2% ↑ 0.8 pt 2026
Capex
€ 5.48M ↑ 10896% 2026 Total € 6.75M
Assets
€ 108.60M ↑ 7% 2026
Equity
€ 86.26M ↓ 1% 2026
Debt
€ 22.24M ↑ 56% 2026
Cash
€ 22K ↑ 1673% 2026
Cashflow
€ 3.03M ↑ 989% 2026 Total € -3.18M
Working capital
€ -8.66M ↓ 573% 2026
Current ratio
0.44 ↓ 67% 2026
Quick ratio
0.44 ↓ 69% 2026
Working capital ratio
0.44 ↓ 68% 2026
Debt
€ 22.24M ↑ 56% 2026
Short-term debt
€ 15.32M ↑ 202% 2026
Long-term debt
€ 6.79M ↓ 24% 2026
Debt / EBITDA
6.24 ↓ 77% 2026
Solvability
79.4% ↓ 6.3 pt 2026
Long term debt ratio
0.08 ↓ 20% 2026
Interest Coverage Ratio
1.29 ↑ 543% 2026
Gross profitability
3.5% ↑ 3.2 pt 2026
Net profitability
0.2% ↑ 0.2 pt 2026
Return On Assets (ROA)
0.13 ↑ 406% 2026
Return On Equity (ROE)
0.16 ↑ 430% 2026
Customer credit
35.74 ↑ 2% 2026
Supplier credit
63.57 2026
Days Sales Outstanding (DSO)
35.74 ↑ 2% 2026
Days Sales of Inventory (DSI)
37.74 2026
Taxes
€ 77K ↑ 147% 2026 Total € 447K
Salaries and Social Security Contributions
€ 1.47M ↑ 130% 2026 Total € 4.02M
Employees
187 ↑ 397% 2026
Staff cost per employee
€ 8K ↓ 54% 2026